(Q44968373)

English

Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles

scientific article published on 6 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

invasive fungal infections

1 reference

based on heuristic

inferred from title

Alessandro Busca

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Chiara Maria Dellacasa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ernesta Audisio

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Filippo Marmont

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Anna Maria Barbui

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michele Falda

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Francesco Giuseppe De Rosa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Chiara Frairia

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Bernardino Allione

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Stefano D'Ardia

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Semra Aydin

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Clara Pecoraro

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sara Manetta

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

315-320

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Posaconazole: clinical pharmacology and potential for management of fungal infections

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational study

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Changes in causes of death over time after treatment for invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

The role of antifungal treatment in hematology

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Contribution of Galactomannan Antigen Detection in BAL to the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000142

21 January 2018

Identifiers

10.1179/1973947813Y.0000000142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24075616%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44968373&oldid=2059850868"